series-b
Stage
2017
Founded
1
Investors
About
Rege Nephro develops therapeutic drugs for renal diseases using iPS cell technology, focusing on cell therapy and small molecule treatments for conditions like chronic kidney disease (CKD) and autosomal dominant polycystic kidney disease (ADPKD).
Explore Rege Nephro's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.